J LS1-15 The potential for the treatment of relapsed/refractory PTCL: Based on clinical experience with darinaparsin (JSH 2024) - Oct 11, 2024 - Pres time: Oct 11, 2024; 11:20 AM - 12:05 PM; Location: No.15 Kyoto International Conference Center 1F Room H; "Sponsored by Nippon Kayaku Co.,Ltd."
Clinical • Hematological Malignancies • Peripheral T-cell Lymphoma
|
|
Noriko Fukuhara; Daisuke Ikeda
|